000			01583 a2200457 4500
005			20250515195434.0
264		0	_c20100218
008			201002s 0 0 eng d
022			_a1758-1125
024	7		_a10.1258/phleb.2009.009050 _2doi
040			_aNLM _beng _cNLM
100	1		_aColeridge Smith, P
245	0	0	_aSclerotherapy and foam sclerotherapy for varicose veins. _h[electronic resource]
260			_bPhlebology _cDec 2009
300			_a260-9 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAir
650	0	4	_aCarbon Dioxide _xadministration & dosage
650	0	4	_aClinical Trials as Topic
650	0	4	_aDetergents _xadministration & dosage
650	0	4	_aDosage Forms
650	0	4	_aEmbolism, Air _xetiology
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInjections, Intravenous
650	0	4	_aMicrobubbles _xadverse effects
650	0	4	_aPolidocanol
650	0	4	_aPolyethylene Glycols _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aSaphenous Vein
650	0	4	_aSclerosing Solutions _xadministration & dosage
650	0	4	_aSclerotherapy _xadverse effects
650	0	4	_aSolutions
650	0	4	_aTreatment Outcome
650	0	4	_aUltrasonography, Doppler, Duplex
650	0	4	_aUltrasonography, Interventional
650	0	4	_aVaricose Veins _xtherapy
650	0	4	_aVision Disorders _xetiology
773	0		_tPhlebology _gvol. 24 _gno. 6 _gp. 260-9
856	4	0	_uhttps://doi.org/10.1258/phleb.2009.009050 _zAvailable from publisher's website
999			_c19335721 _d19335721